Skip to content
CLXClorox

What Is CLX Fair Value?

Clorox (CLX) fair value estimate using multiple valuation models, updated daily.

As of August 29, 2026, Clorox (CLX) has a composite fair value estimate of $67.32 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $102.53, suggesting the stock is overvalued by 34.3%.

Data as of August 29, 2026 (today)

Composite Fair Value

Overvalued4 of 4 models

$67.32

vs. current price of $102.53(-34.3%)

Undervalued$67.32Overvalued
$102.53

How Is CLX Fair Value Calculated?

Four independent models estimate what CLX is worth. Each uses different inputs and assumptions. The composite blends them by weight.

CLX Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$76.92

-25.0%

Overvalued

Inputs used

FCF: 440.3MGrowth: 6.7%Discount: 6%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$124.47

+21.4%

Undervalued

Inputs used

Dividend: $5.00/yrReq. Return: 7%Growth: 3.3%

CLX Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$9.86

-90.4%

Overvalued

Inputs used

EPS: $5.81Book Value: $0.74

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$58.07

-43.4%

Overvalued

Inputs used

EPS: $5.81Growth: 6.7%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$76.92Overvalued

Current price $102.53 is 25.0% above this estimate

CheapFair ValueExpensive
6.7%
0.0%30.0%
6.4%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$469.5M$441.4M
Year 2$500.8M$442.5M
Year 3$534.1M$443.6M
Year 4$569.6M$444.8M
Year 5$607.4M$445.9M
Year 6$647.8M$447.0M
Year 7$690.9M$448.2M
Year 8$736.9M$449.3M
Year 9$785.9M$450.5M
Year 10$838.1M$451.6M
Terminal Value$22.15B$11.93B

What Are CLX's Key Financial Metrics?

Earnings & Growth

Current Price

$102.53

EPS (TTM)

$4.76

Forward P/E

16.3

Profit Margin

8.7%

Cash & Balance Sheet

Free Cash Flow

110.4M

EBITDA

1.1B

Book Value

$0.74

Total Debt

5.6B

What Do Analysts Say About CLX?

Low

$77.00

Average

$101.65

High

$154.00

Upside

-0.9%

Current $102.53Avg Target $101.65Hold17 analysts

CLX Fair Value FAQ

What is the fair value of CLX?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CLX's estimated fair value is $67.32. The stock is currently trading at $102.53, which makes it overvalued by our analysis.

How is CLX's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is CLX overvalued or undervalued?

Based on our analysis, CLX is overvalued. The current price of $102.53 is 34.3% above our estimated fair value of $67.32.

What do Wall Street analysts say about CLX?

17 analysts cover Clorox with a consensus rating of "Hold." The average price target is $101.65, ranging from $77.00 to $154.00. This implies 0.9% downside from the current price.